Clinuvel Pharmaceuticals Market Cap

Clinuvel Pharmaceuticals has a market cap or net worth of 460.41 million as of April 28, 2026. Its market cap has decreased by -14.47% in one year.

Market Cap

460.41M

Enterprise Value

227.73M

Revenue

96.30M

Ranking

n/a

PE Ratio

14.18

Stock Price

9.32

Market Cap Chart

Since February 13, 2001, Clinuvel Pharmaceuticals's market cap has increased from 5.23M to 460.41M, an increase of 8,710.49%. That is a compound annual growth rate of 19.43%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	460.41M	-26.39%
Dec 31, 2025	625.50M	3.84%
Dec 31, 2024	602.36M	-24.90%
Dec 29, 2023	802.04M	-25.09%
Dec 30, 2022	1.07B	-20.36%
Dec 31, 2021	1.34B	21.91%
Dec 31, 2020	Pro	Pro
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Racura Oncology	517.08M
Starpharma Holdings	303.23M
Opthea	738.77M
Tetratherix	240.12M
Orthocell	236.04M
Dimerix	234.15M
Clarity Pharmaceuticals	1.16B
PYC Therapeutics	1.27B

Market Cap Rankings